Back to Search
RICHARD NAGLE, MD
MD
Diagnostic Radiology Physician
NPI: 1609875913Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
MD028963E(PA)
Research & Publications (20)
Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer.
PMID 19244123·Cancer Res·2009
7-preclinical
Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.
PMID 19491258·Cancer Res·2009
7-preclinical
The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.
PMID 18958175·PLoS One·2008
7-preclinical
Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
PMID 18196535·Prostate·2008
8-other
Sympathetic nerves in the tarsal tunnel: implications for blood flow in the diabetic foot.
PMID 18594404·Plast Reconstr Surg·2008
8-other
The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.
PMID 18268112·Cancer Epidemiol Biomarkers Prev·2008
3-trial
Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.
PMID 18058812·Prostate·2008
8-other
Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells.
PMID 17534446·Neoplasia·2007
8-other
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility.
PMID 17536315·Appl Immunohistochem Mol Morphol·2007
4-observational
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study.
PMID 17557954·J Clin Oncol·2007
3-trial
Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer.
PMID 17687336·Br J Cancer·2007
8-other
Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer.
PMID 17706870·Pain·2007
7-preclinical
A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors.
PMID 17325667·Oncogene·2007
8-other
Breast cancer among Hispanic and non-Hispanic White women in Arizona.
PMID 18065856·J Health Care Poor Underserved·2007
8-other
Integrin alpha6 cleavage: a novel modification to modulate cell migration.
PMID 17303120·Exp Cell Res·2007
8-other
90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression.
PMID 16245278·Prostate·2006
8-other
Expression of mTOR signaling pathway markers in prostate cancer progression.
PMID 16652388·Prostate·2006
8-other
Human laminin-5 and laminin-10 mediated gene expression of prostate carcinoma cells.
PMID 16804886·Prostate·2006
8-other
Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse.
PMID 17106247·Cancer Biol Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 201 STATE ST
ERIE, PA 16550 - Phone
- (814) 877-6000
Quick Facts
- NPI
- 1609875913
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile